H.C. Wainwright Lifts Ocular Therapeutix, Inc. (OCUL) Price Target Following Intravitreal Implant FDA Submission

Ocular Therapeutix Inc. (NASDAQ:OCUL) is one of the champion biotech stocks to bargain according to Wall Street analysts. On December 8, H.C. Wainwright reiterated a Buy standing connected Ocular Therapeutix Inc. (NASDAQ:OCUL) and raised the terms people to $21 from $19.

The probe steadfast remains assured astir the company’s outlook pursuing the submission of a caller cause exertion for AXPAXLI, its 450 µg axitinib intravitreal implant. The institution has already received a boost from FDA commissioner Marty Makary, who reiterated that the bureau volition lone necessitate 1 pivotal objective proceedings alternatively of 2 for caller cause approvals.

Ocular Therapeutics is connected people to present topline results successful the archetypal 4th of adjacent twelvemonth successful its Phase 3 SOL-1 trial. It plans to leverage the 505(b)(2) regulatory pathway, which is expected to shorten the reappraisal timeline for its campaigner drug, AXPAXLI.

“At Ocular Therapeutix, we person ever been courageous, opportunistic, and bold successful our efforts to redefine retina,” said Pravin U. Dugel, Executive Chairman, President, and CEO of Ocular Therapeutix. “Based connected caller developments, we present mean to taxable our NDA for AXPAXLI successful bedewed AMD soon aft SOL-1 twelvemonth 1 data, assuming affirmative results.”

Ocular Therapeutix Inc. (NASDAQ:OCUL) is simply a biopharma institution that develops, manufactures, and sells innovative oculus treatments for superior oculus diseases, utilizing its proprietary hydrogel exertion to present drugs straight to the eye, reducing the request for predominant drops and improving outcomes for conditions similar bedewed AMD, glaucoma, and post-surgery pain/inflammation.

While we admit the imaginable of OCUL arsenic an investment, we judge definite AI stocks connection greater upside imaginable and transportation little downside risk. If you're looking for an highly undervalued AI banal that besides stands to payment importantly from Trump-era tariffs and the onshoring trend, spot our escaped study connected the best short-term AI stock.

READ NEXT: 12 Best Consumer Goods Stocks Billionaires Are Quietly Buying and Goldman Sachs Penny Stocks: Top 12 Stock Picks.

Disclosure: None. This nonfiction is primitively published at Insider Monkey.